金山辦公(688111.SH):奇文N維近日累計減持1.15%股份
格隆匯1月29日丨金山辦公(688111.SH)公佈,公司於2020年11月24日披露在上海證券交易所網站的《金山辦公關於5%以上股東減持股份計劃公吿》,公司股東奇文N維擬通過大宗交易或詢價轉讓、集中競價的方式減持其所持有的公司股份合計不超過1267萬股,擬減持股份佔公司總股本的比例約為2.75%。
截至目前,本次權益變動信息披露義務人持有上市公司股份減持比例再次達到1%,將從15.19%減少至14.05%,本次權益變動後,奇文N維合計持有公司6474.78萬股,佔公司總股本的14.05%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.